Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RIBT re-testing the 1.00 and 50 MA support level, so far so good. Volume on the pullback is pretty light, so a good sign. Could use some news flow to help get another up leg moving. As you said, the next target should be the 100 MA (1.39), and the broader 1.25-1.50 area.
---
Yes, RIBT looking good. It went right through 1.00 and the 50 MA without a problem. Also closed right at the high of the day, and then moved up to 1.15 in the aftermarket :o) And volume is decent, and no sign yet of a high volume blow off day that might mean a near term top.
I see what you mean about the gap from mid-Oct, which also corresponds to the 100 MA and also the Oct-Nov trading range. So that looks like the obvious target to watch -- 1.25-1.50 area. Then with some news flow, it might conceivably make a run up to 2 . Looks like momentum is building :o)
Fwiw I decided to re-enter the market modestly. Only a 2% stock allocation so far, but plan to gradually add via dollar cost average into the S+P 500 with 1 share of SPY per day. Nothing dramatic, but I figure by Summer/Fall the bear market could be winding down, so might as well have some exposure to stocks again. I figure maybe a 15% stock allocation by Summer, enough to participate, but not enough to require daily Tagamet :o)
---
---
$RIBT should close above the 50 day MA. Next is the 100 day also a gap to fill back on October 18th, double resistance around the same price.
https://stockcharts.com/h-sc/ui?s=RIBT&p=D&yr=0&mn=5&dy=0&id=p94272385940
gap>
https://finance.yahoo.com/quote/RIBT/history?p=RIBT
Volume coming up for RIBT. Should be interesting to see how it closes today, and then next week's activity :o)
---
RIBT starting to get more volume, so a good sign. Rising price on rising volume improves the validity of an up move, and it's good that the gains are steady and incremental, suggesting a longer move.
The big question now is the 1.00 level and the 50 MA (1.03). Being together they represent a bigger barrier, but once breached convincingly they then can become stronger support.
Beyond 1.00-1.03 is the mid-Oct to mid-Nov trading range, which centers around 1.25. So that would be the next target to watch once it's definitively through 1.00-1.03. Could first get some back/fill for a while around 1.00-1.03, or alternately it might go more quickly up to 1.25 and then pause for back/fill and to retest 1.00-1.03. Should be interesting :o)
I should have picked up some RIBT in late Dec like you did, but I've sworn off active trading, so it's just for fun. But sometimes chart setups are so compelling, it gets very tempting. But I've seen perfect setups blow up, or an external event will tank the broader market, so there's always risk..
The reason charts/TA work is that almost everyone on Wall St and his brother are using the same TA signals, so they become self fulfilling. Everyone uses the 50 MA, 200 MA, and previous trading zones as their support and resistance areas. They all use the same candlestick pattern signals (hammer, shooting star, etc), and chart formations (ascending triangle, head + shoulders, etc). Also volume signals.
---
It looks like the Fed will do a milder 1/4 point rise on Feb 1 (rather than 1/2 point), per Nick Timiraos (article below), who is the Fed's unofficial mouthpiece at the Wall Street Journal. It is widely known on Wall St that the Fed uses Timiraos to disseminate the Fed's guidance to the investment world. So Timiroas' articles are a 'must read' for investors, though you can usually get the main gist from the headline -
>>> Inflation Report Tees Up Likely Quarter-Point Fed Rate Rise in February. Improving inflation data suggest officials will consider a smaller increase than in recent months
The Wall Street Journal
By Nick Timiraos
Jan. 12, 2023
https://www.wsj.com/articles/inflation-report-tees-up-likely-quarter-point-fed-rate-rise-in-february-11673535597
Fresh data showing inflation eased in December are likely to keep the Fed on track to reduce the size of interest-rate increases to a quarter-percentage-point at its meeting that concludes on Feb. 1.
The Labor Department reported Thursday that consumer prices fell in December, largely reflecting lower energy prices. The consumer-price index declined 0.1% from November. The index was up 6.5% for the year, down from a recent peak increase of 9.1% in June.
The core CPI index, which excludes volatile food and energy items, rose 0.3% from November, and the 12-month increase edged lower to 5.7%, from 6.6% in September. On a three-month annualized basis, core inflation was 3.1%, the lowest such rate in more than a year and down from 7.9% in June.
Fed officials have kept their options open on whether to raise rates by either a quarter percentage point or a half percentage point at their next meeting, saying that the decision would be strongly guided by the latest data about the state of the economy.
But the improving inflation data suggest officials will strongly consider the smaller increase of a more traditional quarter point, or 25 basis points. It takes time for them to see the full effects of their policy actions, and they are trying to avoid causing unnecessary declines in employment and growth.
“In my view, hikes of 25 basis points will be appropriate going forward,” said Philadelphia Fed President Patrick Harker in remarks Thursday morning.
After holding rates near zero for two years following the onset of the coronavirus pandemic, officials raised borrowing costs more aggressively last year than at any time since the early 1980s. They lifted their benchmark federal-funds rate most recently by a half percentage point in December, to a range between 4.25% and 4.5%, following four consecutive increases of 0.75 percentage point.
Fed policy makers want the economy to slow down to cool demand and reduce inflation. Recent data suggest hiring has held steady, but a separate Labor Department report last week indicated wage growth moderated at the end of last year. Wage figures are important to the Fed because officials are nervous that the labor market’s strength could sustain wage growth that keeps inflation, as measured by their preferred Commerce Department gauge, above their 2% target.
Prices of goods such as used cars are declining, a development the Fed has anticipated for more than a year. There is evidence that soaring rents and other housing costs are set to cool notably amid a sharp slowdown in demand, though that won’t be immediately reflected in the CPI because of how it is constructed.
Fed Chair Jerome Powell has recently shifted the focus away from core inflation measures toward an even narrower subset of labor-intensive services by excluding prices for food, energy, shelter and goods. Officials believe that category could help show whether labor shortages that have been pushing up wages are passing through to consumer prices.
“We welcome these better inflation reports…but I think we’re realistic about the broader project,” Mr. Powell said last month. Despite progress on goods and housing inflation, “the big story will really be the rest of it, and…that’s going to take time.”
In an interview Monday, San Francisco Fed President Mary Daly said, “I’m going to be paying a lot of attention to core services ex-housing because I’d like to see some improvement there.” That subset of prices rose 0.26% in December, well below last year’s monthly average of around 0.5%, according to economists at Morgan Stanley.
Officials are trying to balance the risk of raising rates too much with the risk of not doing enough to slow down spending and investment, which could allow higher inflation to become entrenched.
Mr. Powell said last month it was “broadly right” that the Fed’s best way to manage the risk of over-tightening would be to slow rate increases to smaller 0.25-point increments as soon as the central bank’s next meeting.
“It makes a lot of sense, it seems to me—particularly if you consider how far we’ve come,” Mr. Powell said. But he said the Fed’s actions would depend significantly on new information about the state of the economy and borrowing conditions.
Ms. Daly appeared to endorse Mr. Powell’s thinking about how to balance the risks facing the Fed on Monday. “When you’re being seriously data dependent, doing it in more gradual steps does give you the ability to respond to incoming information and account for those lags,” she said.
Most Fed policy makers last month anticipated that they would need to raise the fed-funds rate to a level above 5% this year. “I think it would behoove the committee to get into that zone as soon as we can without ignoring the data,” St. Louis Fed President James Bullard told reporters last week.
<<<
---
RIBT up to 1.00 and the 50 MA area, so will be interesting to see what happens next. Volume still somewhat muted, but maybe some news flow could be coming? Either way, a nice looking recovery underway :o)
In the broader market, the S+P 500 is testing its 200 MA area, and looks like it might keep moving up to test the Nov/Dec highs. I figure the markets may remain somewhat buoyant as long as there are no geopolitical events to upset the apple cart.
Another Fed rate decision in less than 3 weeks away, so there may be some growing angst leading up to that. The Fed doesn't like to see a strong stock market in the current environment ('wealth effect', inflation), so they may need to interject some hawkish verbiage. Just a guess. Fwiw, I'm still on the sidelines, but with cash/T-bills over 4% and no risk, I figure it's not too shabby :o)
---
>>> New methods, sources spurring plant protein innovation
Food Business News
01.09.2023
By Jeff Gelski
https://www.foodbusinessnews.net/articles/22980-new-methods-sources-spurring-plant-protein-innovation
KANSAS CITY — Precision fermentation and canola protein may accelerate plant protein innovation. Seaweed protein also may make a splash in the future.
The plant protein category by no means has stayed in the slow lane. MarketsandMarkets, Northbrook, Ill., estimated the global plant-based protein market at $12.2 billion in 2022 and forecasts it to generate a compound annual growth rate of 7.3% between 2022 and 2027, reaching $17.4 billion.
Precision fermentation may accelerate product development in the plant-based category. ICL Food Specialties, a division of Tel Aviv, Israel-based ICL Specialty Products Inc., and Protera Biosciences, a food technology startup and designer of novel proteins, formed a partnership late in 2022. ICL and Protera plan to develop and commercialize protein-based ingredients using precision fermentation.
Protera’s Madi platform predicts and matches the structure and functionality of vegetable proteins. The platform designs proteins from a database of over 1.5 billion edible protein sequences and applies precise fermentation parameters for producing the proteins. The new ingredients may replace texturizers, stabilizers and preservatives.
“These proteins can be produced in large scale by Protera’s precision fermentation technology using sugars as the main raw material,” said Rado Sporka, vice president of the food specialties commercial business for ICL. “The production process is similar to traditional fermentation process for alcoholic beverage production.”
The ingredients should become available in the next few years once regulatory approvals are received, he said.
ADM, Chicago, has invested in precision fermentation as well.
“We know how important fermentation and precision fermentation are to the growing alternative protein landscape,” said Leticia Goncalves, president of global foods for ADM. “As such, we’re helping to spur activity with ‘fermentation-as-a-service.’ While extensive capabilities in food-grade fermentation are required for the processing, lab services and consulting needs of food and beverage companies, fermentation-as-a-service helps push innovation forward more efficiently.”
ADM and the Asia Sustainable Foods Platform, which focuses on accelerating the commercialization of sustainable foods in Asia, in 2022 inaugurated their joint venture company called ScaleUp Bio. The joint venture will provide contract development and manufacturing organization services for precision fermentation for food applications.
Hello, canola protein
Many in the food industry may associate canola with edible oils, but canola also has emerged as a source of plant protein.
Royal DSM, Delft, The Netherlands, in November 2022 launched Vertis CanolaPro, a canola protein isolate. CanolaPro has been shown to improve the bite and texture of meat and fish alternatives, and it creates a smoother mouthfeel in dairy alternatives and performance nutrition products, according to DSM. The ingredient has a protein digestibility-corrected amino acid score (PDCAAS) of 1, which is on par with soy or whey.
CanolaPro and Avril Group, a processor and financer in the vegetable oils and protein sector based in France, formed a joint venture that produces CanolaPro at a facility in Dieppe, France.
Merit Functional Foods, Winnipeg, Man., already offers canola protein ingredients. The company opened a 94,000-square-foot plant-based protein facility in Winnipeg early in 2021. The facility processes both pea and canola.
On the horizon
P&S Intelligence, New York, estimated the worldwide seaweed protein market to be about $513.7 million in 2021 and forecast it to have a CAGR of 12% from 2021 to 2030, reaching $1.4 billion by 2030. The food sector accounted for over 80% of the total income from the sale of seaweed proteins in 2021, according to the company.
“On the horizon, we will see emerging plant protein sources like algae, sunflower, lupin, chickpea and ancient grains, including amaranth and sorghum, incorporated into various alternative formulations,” said Ms. Goncalves of ADM. “However, these sources don’t have mainstream awareness, and it will take time for them to gain the same general consumer recognition as conventional sources like soy, wheat and pea.”
ADM has invested in Nature’s Fynd, which is leveraging fungi to help produce fermented mycoprotein.
Cellular or cultured meat may impact the plant protein category as well. ADM is supporting Believer Meats in its development of cultivated meats that are grown in a laboratory from animal cells, said Allyson Fish, president of alternative proteins for ADM.
“Additionally, as technology advances, we anticipate there will also be an uptick in blends and hybrids of plant and cultured sources, plant and fermented sources, and more,” Ms. Fish said. “Blending unfamiliar sources with familiar ones helps create a lower barrier of entry for consumers, leading to heightened future acceptance. This is similar to the way many people originally accepted alternative offerings, as many offerings were created from hybrids of animal protein and plant protein. This trend has the potential to re-emerge to drive consumer acceptance and support the expanding alternative protein arena.”
<<<
---
$RIBT - Yep the last part of the day the total buy vese sell was 11,000 buy, sell 15,500. It ended at 21,642 buy - 17,885 sell 7355?
Some break through of some keep moving averages, if it breaks through the 34 day MA, the 50 is not far away, the 100 day at $1.53. might prove resistance unless news comes out. I hope to see it over $1.00 soon.
https://stockcharts.com/h-sc/ui?s=RIBT&p=D&yr=0&mn=3&dy=0&id=p25829017290
RIBT continues to climb :o)
Still could use more volume, but a nice burst came in near the close today. A test of 1.00 should be forthcoming :o)
---
New methods, sources spurring plant protein innovation
https://www.foodbusinessnews.net/articles/22980-new-methods-sources-spurring-plant-protein-innovation
Precision fermentation and canola protein may accelerate plant protein innovation. Seaweed protein also may make a splash in the future.
The plant protein category by no means has stayed in the slow lane. MarketsandMarkets, Northbrook, Ill., estimated the global plant-based protein market at $12.2 billion in 2022 and forecasts it to generate a compound annual growth rate of 7.3% between 2022 and 2027, reaching $17.4 billion.
Precision fermentation may accelerate product development in the plant-based category. ICL Food Specialties, a division of Tel Aviv, Israel-based ICL Specialty Products Inc., and Protera Biosciences, a food technology startup and designer of novel proteins, formed a partnership late in 2022. ICL and Protera plan to develop and commercialize protein-based ingredients using precision fermentation.
Protera’s Madi platform predicts and matches the structure and functionality of vegetable proteins. The platform designs proteins from a database of over 1.5 billion edible protein sequences and applies precise fermentation parameters for producing the proteins. The new ingredients may replace texturizers, stabilizers and preservatives.
“These proteins can be produced in large scale by Protera’s precision fermentation technology using sugars as the main raw material,” said Rado Sporka, vice president of the food specialties commercial business for ICL. “The production process is similar to traditional fermentation process for alcoholic beverage production.”
The ingredients should become available in the next few years once regulatory approvals are received, he said.
ADM, Chicago, has invested in precision fermentation as well.
“We know how important fermentation and precision fermentation are to the growing alternative protein landscape,” said Leticia Goncalves, president of global foods for ADM. “As such, we’re helping to spur activity with ‘fermentation-as-a-service.’ While extensive capabilities in food-grade fermentation are required for the processing, lab services and consulting needs of food and beverage companies, fermentation-as-a-service helps push innovation forward more efficiently.”
ADM and the Asia Sustainable Foods Platform, which focuses on accelerating the commercialization of sustainable foods in Asia, in 2022 inaugurated their joint venture company called ScaleUp Bio. The joint venture will provide contract development and manufacturing organization services for precision fermentation for food applications.
Hello, canola protein
Many in the food industry may associate canola with edible oils, but canola also has emerged as a source of plant protein.
Royal DSM, Delft, The Netherlands, in November 2022 launched Vertis CanolaPro, a canola protein isolate. CanolaPro has been shown to improve the bite and texture of meat and fish alternatives, and it creates a smoother mouthfeel in dairy alternatives and performance nutrition products, according to DSM. The ingredient has a protein digestibility-corrected amino acid score (PDCAAS) of 1, which is on par with soy or whey.
CanolaPro and Avril Group, a processor and financer in the vegetable oils and protein sector based in France, formed a joint venture that produces CanolaPro at a facility in Dieppe, France.
Merit Functional Foods, Winnipeg, Man., already offers canola protein ingredients. The company opened a 94,000-square-foot plant-based protein facility in Winnipeg early in 2021. The facility processes both pea and canola.
On the horizon
P&S Intelligence, New York, estimated the worldwide seaweed protein market to be about $513.7 million in 2021 and forecast it to have a CAGR of 12% from 2021 to 2030, reaching $1.4 billion by 2030. The food sector accounted for over 80% of the total income from the sale of seaweed proteins in 2021, according to the company.
“On the horizon, we will see emerging plant protein sources like algae, sunflower, lupin, chickpea and ancient grains, including amaranth and sorghum, incorporated into various alternative formulations,” said Ms. Goncalves of ADM. “However, these sources don’t have mainstream awareness, and it will take time for them to gain the same general consumer recognition as conventional sources like soy, wheat and pea.”
ADM has invested in Nature’s Fynd, which is leveraging fungi to help produce fermented mycoprotein.
Cellular or cultured meat may impact the plant protein category as well. ADM is supporting Believer Meats in its development of cultivated meats that are grown in a laboratory from animal cells, said Allyson Fish, president of alternative proteins for ADM.
“Additionally, as technology advances, we anticipate there will also be an uptick in blends and hybrids of plant and cultured sources, plant and fermented sources, and more,” Ms. Fish said. “Blending unfamiliar sources with familiar ones helps create a lower barrier of entry for consumers, leading to heightened future acceptance. This is similar to the way many people originally accepted alternative offerings, as many offerings were created from hybrids of animal protein and plant protein. This trend has the potential to re-emerge to drive consumer acceptance and support the expanding alternative protein arena.”
Thanks, it might be 2 stocks posts at iFib, could be wrong.
I'm thinking the gold chart might need a breather to consolidate after the big runup from Oct, especially since the US dollar appears to be ready for a rebound after its big drop. Just a guess though.
But the RIBT chart looks really tempting right now. Fwiw, I posted this over on the Orion and Momo boards (below), so it might help move things along. Those two boards have ~25,000 posters, so it should grab some eyeballs at least :o)
I think you can put a post on up to 3 boards without running afoul of the I-Hub rules. That's how it was back in my trading days anyway - anything over 3 and it is considered spam. On a thinly traded stock like RIBT it will help to get more people aware of the stock, and you might also get some investors with a longer term interest. Can't hurt trying anyway :o)
>> RIBT - nice chart setup for bounce <<
---
Interesting old fashioned moving averages on RIBT, the 10.20 and 50. If you are right about $1.00, the 50 day might temporarily stop it.
https://finviz.com/futures_charts.ashx?p=d1&t=GC
100 and 200>>>
https://stockcharts.com/h-sc/ui?s=RIBT&p=D&yr=0&mn=7&dy=0&id=p06236111974
I am hoping it goes to the mid 2's with no PR. Then the miracle PR from there, lol
I posted RIBT ar Orions board a couple of years back, and again last year. I drew no interest. My post at RIBT today>>>
RIBT needs a name and symbol change. So many people have lost big money on this stock it has a bad name stock market wide. Plus Rice Bran is not all they do. They now have oats and barley and looking for more. My best shot is "Grain Ingredients" symbol RBOB (Rice Bran} , {Oats},{Barley}. GRIN is taken.
They did change the name under John Short from Nutracea, symbol NTRZ.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170873675
Gold?>>>
https://finviz.com/futures_charts.ashx?p=d1&t=GC
RIBT has a super nice chart setup right now for a move back to 1.00. Beyond that is tough to say, but the chart says 1.00 is coming (assuming the overall stock market doesn't fall out of bed). Both 1:00 and the 50 MA are clearly beckoning :o)
Since the volume is relatively low, one way to help get RIBT moving would be to post about it on a few of I-Hub's busier trading boards. The near term chart setup is so tempting and obvious right now that it would almost certainly generate some added buying to hasten its rebound. Daily volume in dollar terms is only running ~ $40-50 K, so it wouldn't take much new buying to send it skyward :o)
ORIONS Money Stocks -
https://investorshub.advfn.com/orions-money-stocks-12753
MOMO'S BREAKOUT BOARD -
https://investorshub.advfn.com/MOMOS-BREAKOUT-BOARD-4929
---
With gold, I think what really helped light a fire under it in the 2000s was the creation of the various metals ETFs (GLD, SLV) in the mid-2000s, along with the mining ETFs like GDX, SIL. That made it super easy for investors to pile in, and up she went.
Right now it's starting to look like the US dollar could be ready for a bounce back after the huge drop since Oct. How long the dollar bounce lasts, who knows, but it could cause the metals to retrace and consolidate for a while.
My gold story goes back to when it was ~250 range and I bought some US and foreign gold numismatic type coins. It was exciting to see gold reach 700 so I sold them at a nice profit, but of course it continued to zoom, eventually reaching 2000/oz, so got off the bus too early. Still a nice profit though.
For exposure to the miners I would mainly stick to the broad ETFs like GDX and SIL, and for small caps there is GDXJ and SILJ. Jim Rickards recommends a max of 10% allocation to the metals sector, which seems like a wise strategy all things considered. Best not to go too overboard in any sector :o)
---
I do agree that gold looks great here.
Now for my gold story>>>>
A ffriend of mine and I were buying gold and silver stocks in the lat 90's and down on them. After 9/11, I was surpreised gold did not go up, bur I was amazed in the aftermathe it did not fall. So my friend and mine kept on our annual IRA contribution gold and silver stocks. It inched up, but really took off in. My biggest holding was Sunshine Mining, a silver company. Six months before gold and silver took off, it went BK. I was my biggest holding by far. Six months before the BK, the company put out their annual report and it was like GLOWING. Any way, I broke even on my gold and silver stocks, would have had a double if Sunshine had not gone belly up.
This is the best the gold chart has looked for some time. It put in that Oct/Nov bottom just as the US dollar peaked. Gold then zoomed as the dollar fell, and now has broken out of an ascending triangle pattern, so looking good. It will need some back+fill, but looks like it will test 2000 again before too long.
I look at gold as 'disaster insurance' for when everything else really falls apart. So you hope that gold doesn't do too well since that means regular investments are still OK.
>> The real world got lost maybe 100 years ago? <<
Yes, the creation of the Federal Reserve was the pivotal event (1913), when the bankster Mafia took over.
---
What ever is going on is fake. The real world got lost maybe 100 years ago? 2022 saw the most inflation in quite a while. The fake Ukraine war, the USA national debt spiked, millions of people coming in from Mexico and they give them money we don't have. Another fake election. Naked Shorts in the news again. All this and gold for 2022 basically unchanged. As bad as thinks look, maybe another sucker rally for stocks? Who knows.
https://finviz.com/futures_charts.ashx?p=d1&t=GC
Yes, I hear ya. The state of the US / world has me spooked also. Investors would like things as they were (dovish Fed and 'buy the dip'), but I'm figuring on darker days ahead. Could be wrong, but not liking the looks of things.
But what could change the outlook considerably -
- Ukraine war ends
- China-Covid resolves without a repeat of Spring 2020
- Inflation comes down / stays down
---
My hope is $RIBT gets to 2 or more, then a great PR and spike to $6.50 or more and I am gone from the market. Stuff coming out lately about the CIA/Mafia/Vatican connection going back many years, geez. I always wondered why big drug busts in my area always involved "New operations in town" and never the old established drug pushers. Guessing "The war on drugs" was a war on the CIA/Mafia drug business competition. Oh and why be in Afghanastan when cocaine has been replaced with fentantl coming through Mexico. I fear the great reset will come soon and stocks.....who knows. Our whole government is being exposed as fake.
>> BABYF <<
I still look at the chart, though it's not something I would invest in these days. BABYF is one of the most 'neurotic' stocks in how it trades, with lots of head-fakes and apparent 'painting the tape' type activity. It would be interesting to watch it on Level 2 to get a better idea. Seems like a stock to stay far away from lol..
Much better off with larger cap stocks, although they can be hazardous too. Just too many landmines out there right now imo, so I'm settling for the 4% from cash/T-bills. But there are stock bargains galore, especially in the tech related sectors and smaller caps. But cash/T-bills allow me to sleep at night, so it's a 'Tagamet-free' approach for now, but maybe later in the year will be time for a re-entry into the market :o)
---
I here stuff 2 and 3 rd hand. If their is news it won't be fluff and in December it was "January or late January."Don't count on it.
Let's get ELSE rolling too!!!!
Nice bounce for RIBT. Looks like 1.00 is coming soon :o)
That also corresponds to the 50 MA (1.07 and falling), so it should be a good test of the strength of this rebound. Maybe some good news flow and press releases coming soon also?
---
Beyond Soylent Green - >>> New York becomes 6th US state to green light human composting law
Fox News
by Pilar Arias
Jan 1, 2023
https://www.msn.com/en-us/news/us/new-york-becomes-6th-us-state-to-green-light-human-composting-law/ar-AA15RS7E
New York has become the sixth state in the United States to legalize natural organic reduction, popularly known as human composting, as a method of burial.
Democratic Gov. Kathy Hochul signed the legislation on Saturday. Washington was the first state to legalize human composting in 2019, followed by Colorado and Oregon in 2021 and Vermont and California in 2022.
"I am committed to having my body composted and my family knows that," Howard Fischer, a 63-year-old investor living north of New York City, told The Associated Press. "Whatever my family chooses to do with the compost after it’s done is up to them."
The alternative, green method of burial aligns with Fischer's philosophical view on life: to live in an environmentally conscious way.
The process involves the body of the deceased being placed into a reusable vessel, along with plant material such as wood chips, alfalfa and straw. The organic mix creates the perfect habitat for naturally occurring microbes to do their work, quickly and efficiently breaking down the body in about a month’s time.
The end result is a cubic yard stack of nutrient-dense soil amendment, the equivalent of about 36 bags of soil, that can be used to plant trees or enrich conservation land, forests or gardens.
For urban areas such as New York City where land is limited, it can be seen as a pretty attractive burial alternative.
Even though human composting is now legal in The Empire State, not everyone is on board with the idea.
"A process that is perfectly appropriate for returning vegetable trimmings to the earth is not necessarily appropriate for human bodies," Dennis Poust, executive director of the New York State Catholic Conference, said in a statement. "Human bodies are not household waste, and we do not believe that the process meets the standard of reverent treatment of our earthly remains."
Recompose, a green funeral home specializing in human composting, also known as natural organic reduction, terramation, or recomposition at Recompose Seattle
"Cremation uses fossil fuels and burial uses a lot of land and has a carbon footprint," Katrina Spade, the founder of Recompose, a full-service green funeral home in Seattle that offers human composting, said. "For a lot of folks being turned into soil that can be turned to grow into a garden or tree is pretty impactful."
<<<
---
TY, and I'd like it to get over $2 without a PR, then a PR about their pet food rice bran product replacing yeast going full speed ahead. They stated at their last CC the equipment coagulated and new equipment was being developed. I hear thier main plants are doing exceptional and their main Ag areas are getting well needed rain, even drough stricken California. They has said their best rice bran comes from California.
https://www.wunderground.com/forecast/us/ca/sacramento/38.58,-121.49
https://www.wunderground.com/forecast/us/ca/redding/40.59,-122.39
Looks like some 'January Effect' buying starting for RIBT. I didn't see any company news or filings, but a nice jump on higher volume. It reached 0.88 before selling off, but hopefully more follow through next week :o)
---
That is what I mean they fixed they financial drain at Golden Ridge. They were not getting enough bran and farmers wanted top dollar. They got a new manager and also a respected rice mill owner to get more farmers at a better price and he is the guy who got shares at $1.65 and warrants. I trust his judgement over the rest of us. Call the IR. Golden Ridge is "On fire"!!!
Good night.
Yes, but they had to borrow $3 mil a few months ago on fairly toxic terms just to keep going, which is now almost as much as the $4 mil market cap. So the math is not good, plus the reverse split and continued free fall is ominous. I have a limited ability to fully analyze small stocks, but it seems like going out of business is a real risk here.
That said, some type of Jan effect bounce seems quite possible, and a chance for a quick trade. But longer term success for the company seems like a long shot, not impossible but odds not good. I like following some of these micro plays, but eventually decided on a strict $1000 limit per stock to limit the potential for disaster, and to 'live to fight another day' :o)
---
The last Q3 over Q3 revenue increase was 48%, Book value $2.50, corections in Golden Ridge supply chain solved. Nuff said?
Yes there could very well be a bounce back to 1:00, but much beyond that assumes that the numerous Sept warrants will not get exercised and sold off. 0.70 to 1.00 is a nice % gain, but expecting much beyond that is not so clear, unless RIBT's underlying business does in fact do well. But lots of problems with these tiny stocks, manipulation, lack of funding, lack of profitability, etc.
For a good long term food stock, how about something solid like Hershey (HSY), a 5 bagger over the past decade, plus the dividend. It doesn't have the promise of fast riches, but slow riches :o) Pepsico is another great one, more than tripled over a decade, and a 2.5% dividend.The combination of solid returns and a lack of angst/ulcers make up for the lack of day to day excitement :o)
---
You are missing a wild card that pumped the stock up and the fear of a steep fall that caused over selling.
https://www.bnnbloomberg.ca/stock-trading-influencers-charged-with-114-million-fraud-scheme-1.1859270
RIBT is not involved in this suit since it ended in April 2022 when these same duded were starting to pump up RIBT.
So, fear of other suits are possible involving RIBT, but RIBT would be the victim, not the defendent. Add this to tax selling and I feel RIBT gets to $2.00 with no good news from management, which is possible about their new pet food problem being solved. And the pet food is being made, but the quantity and higher profit from the new equipment will be huge.
But, many Reddit stocks fell when that suit came out, including RIBT. Look at the last week and 1/2 chart of GME, AMC and RIBT, and some selling prior to the week and a half with "people" knowing the suit would come out.>>>>>
https://stockcharts.com/h-sc/ui?s=RIBT&p=D&yr=1&mn=0&dy=0&id=p01199051532
https://stockcharts.com/h-sc/ui?s=AMC&p=D&yr=1&mn=0&dy=0&id=p84464803047
https://stockcharts.com/h-sc/ui?s=GME&p=D&yr=1&mn=0&dy=0&id=p05648346654
RIBT is grossly oversold not from fundamentals, rather from a pump and dump and The US Department of Justice going after the pump and dumpers, IMO.
Looking at the 'January Effect' potential for RIBT, some factors to consider would include - how much of the late year selling has been driven by tax loss selling (investors harvesting losses for tax purposes), and how much has been from the exercise of warrants from the Sept financing?
Looking at the warrant side, as part of the Sept financing there were issued 2.3 mil warrants exercisable at 0.65, and another 2.3 mil warrants exercisable at 1.00. So based on the warrant side, one might expect additional selling of warrant shares to kick in when the stock price gets much above 1.00. So the Jan price bounce could be 'capped' ~1.00 or slightly higher.
Of course there are other factors like the company's news flow and the perception of their business prospects. If the warrant holders see a bonafide turnaround coming for RIBT they might decide to either hang on to their warrants, or exercise and not sell the resulting shares right away.
The good thing is that regular tax loss selling for 2022 will end soon, so that downward pressure component will be gone. But the potential for downward pressure from the warrant side will continue however, from the remaining 0.65 warrants and then from the additional 2.3 warrants at 1.00. The big question will be whether the company can muster a bonafide turnaround in their business.
Anyway, looks like high risk proposition, but GL with it :o) One obvious potential strategy would be for a short term trade based on the current depressed price and the 1.00 target. Just a guess though. You follow the company closely, and thus know more about their longer term prospects, but familiarity can also have a downside due to loss of objectivity, ie the classic 'falling in love with a stock' syndrome. I've done it numerous times over the years, and ended up being wrong about the stock in just about every case (Cortex Pharma, Orchids Paper, PolyMedix-IPIX, SenesTech), so not a great track record with the microcaps. But luckily I never had large positions, and now just follow the microcaps out of general interest. The key takeaway I learned was to never 'bet the farm' :o)
---
>> big oil, like Rockefeller and big railroad barons <<
The real takeover was the creation of the Federal Reserve System in 1913, which is a privately owned cartel. As Henry Ford said - "It is well enough that people of the nation do not understand our banking and monetary system, for if they did, I believe there would be a revolution before tomorrow morning."
The Creature from Jekyll Island -
We will be like China in a few years, socialist(slavery). The USA started losing it's Democracy in the late 1880's with the big oil, like Rockefeller and big railroad barons like Vanderbelt and Hill started buying all the politicians.
DSM squaring the circle of plant-based and animal protein for a ‘holistic food system transformation’
16-Dec-2022 By Katy Askew
Snippet:
Nutrition, health and bioscience company DSM’s business includes solutions it believes will help make the food system more sustainable across both human and animal nutrition. When we caught up with Elisabeth Hirschbichler, VP of Strategy, Innovation and Transformation, she explained this approach supports a ‘holistic food system transformation’.
https://www.foodnavigator.com/Article/2022/12/16/DSM-squaring-the-circle-of-plant-based-and-animal-protein-for-a-holistic-food-system-transformation
https://finance.yahoo.com/quote/DSM.AS/
>> adding big time <<
There might be a short term bounce trade coming, but once a stock gets this beat up (market cap only $4 mil), it gets harder and harder to turn the business around since the required funding gets increasingly toxic. So you could very well be throwing good money after bad. Buying the dip with the S+P 500 is a lot different than doing it with a tiny stock possibly teetering on oblivion. Good luck, but always keep a 'safety net' :o)
---
I am adding big time soon. I got to wait 3 days after a deposit since it is a penny stock now.
Condolences on RIBT, but I wonder if it might be approaching a near term bottom (?)
Since the warrants from the Sept financing are exercisable at 0.65, it is profitable for holders to exercise and sell the resulting shares at anything above that level. So 0.65 might represent a 'floor', at least when it comes to selling pressure from the warrant side. Regular tax loss selling is another source of the current price drop, and that should end in several weeks.
However, looking at the prospects for a January bounce, while the tax selling should be gone at year's end, the 0.65 warrant aspect will still be there as long as the 2.3 mil of warrants are around. There is also a 2nd tranche of 2.3 mil warrants priced at $1 (which can be re-priced lower at a later date), so these could represent an upside barrier at $1 for the share price.
All in all it's a messy picture once these crappy financings enter the picture. You see this a lot with small bio stocks that do desperation financings, as the chronic lack of earnings leads to a 'circling the drain' vortex -
https://irdirect.net/prviewer/release_only/id/4856093
>>> Under the securities purchase agreement, the Investor has agreed to purchase (i) 2,307,500 shares of the Company's Common Stock at a purchase price of $0.65 per share, (ii) warrants to purchase 2,307,885 shares of Common Stock, exercisable for a period of five years following the date of issuance with an exercise price of $0.65 per share, $0.6499 per share of which will be prefunded, and (iii) warrants to purchase 2,307,693 shares of common stock exercisable for a period of five years following the date of issuance with an exercise price of $1.00 per share, which exercise price will be subject to adjustment on the first and second anniversaries of issuance if 110% of the 5-day volume weighted average price of the Company's Common Stock is less than the then-current exercise price. The closing is expected to occur on September 13, 2021, subject to customary conditions. Until the second anniversary of the closing of this offering, the Investor will have the right to participate for up to 45% of the securities offer by the Company in future offerings, subject to certain exceptions, and the Company has agreed to suspend its sale of securities under it's At The Market (ATM) equity issuance program.
<<<
---
Looks like tax selling could be likely for RIBT this year. The chart looks ominous, so will see if 1.00 holds. I see the $3 mil financing in Sept had warrants priced at 0.65, so that might be a potential downside target to watch since anything above that makes it profitable to exercise the warrant and sell the resulting shares. Also, looks like the warrants have an 'adjustment' feature, by which they can be re-priced lower after the 1st and 2nd anniversary. That isn't a factor yet, but can encourage manipulation later as the anniversary date approaches next year.
In my small cap biotech investing days, we used to dread these desperation type financings since once a company is running on fumes, the financing ghouls will take full advantage. Hopefully the company will have some positive developments next year to turn things around, but looks like RIBT is clearly in the 'Danger Will Robinson' category..
https://irdirect.net/prviewer/release_only/id/4856093
>>> Under the securities purchase agreement, the Investor has agreed to purchase (i) 2,307,500 shares of the Company's Common Stock at a purchase price of $0.65 per share, (ii) warrants to purchase 2,307,885 shares of Common Stock, exercisable for a period of five years following the date of issuance with an exercise price of $0.65 per share, $0.6499 per share of which will be prefunded, and (iii) warrants to purchase 2,307,693 shares of common stock exercisable for a period of five years following the date of issuance with an exercise price of $1.00 per share, which exercise price will be subject to adjustment on the first and second anniversaries of issuance if 110% of the 5-day volume weighted average price of the Company's Common Stock is less than the then-current exercise price. The closing is expected to occur on September 13, 2021, subject to customary conditions. Until the second anniversary of the closing of this offering, the Investor will have the right to participate for up to 45% of the securities offer by the Company in future offerings, subject to certain exceptions, and the Company has agreed to suspend its sale of securities under it's At The Market (ATM) equity issuance program.
<<<
---
>>> AgroFresh Solutions rallies on buyout deal with Paine Schwartz Partners
MarketWatch
Nov. 22, 2022
By Steve Gelsi
https://www.marketwatch.com/story/agrofresh-solutions-rallies-on-buyout-deal-with-paine-schwartz-partners-2022-11-22?siteid=yhoof2
AgroFresh Solutions Inc. AGFS, +5.56% rose 4.7% in premarket trades Tuesday after the company confirmed a go-private buyout deal with sustainable food chain investing firm Paine Schwartz Partners. Philadelphia-based AgroFresh said it agreed to be acquired for $3.00 per share. The stock closed at $2.79 a share on Monday, with a market capitalization of $150 million. AgroFresh CEO Clint Lewis said the deal will "provide enhanced flexibility for AgroFresh to build on its strong foundation and advance its mission of preventing food waste and conserving the planet's resources for years to come."
<<<
---
>>> Welcome for US FDA granting green light for cultivated meat
F+D Technology
Nov 18, 2022
https://www.foodanddrinktechnology.com/news/45163/welcome-for-us-fda-granting-green-light-for-cultivated-meat/
Global food awareness NGO, ProVeg International, welcomed the news that Upside Foods has received a “no questions” letter from the US Food and Drug Administration (FDA) for cultivated meat, poultry or seafood.
“This is fantastic news and means that the cultivated meat revolution is changing gear,” Mathilde Alexandre, senior project manager for cellular agriculture at ProVeg, said.
Upside Foods is the first company in the world to receive a “no questions” letter from the FDA, indicating that the company’s cultivated meat is safe to eat.
“This paves the way for cultivated meat to enter the US, a major market, bringing a method of meat production to America that emits less greenhouse gas and does not involve the suffering of animals”, Alexandre said. “It really is a ground-breaking development.”
Research from the UK Food Standards Agency has shown that assurance around the food safety of cultivated meat is one of the top factors for consumers to eat the product. Upside Foods receiving the blessing from the FDA on its production method is a milestone in showing consumers that cultivated meat is safe to eat.
Only Singapore has given regulatory approval for cultivated meat so far, allowing cultivated chicken pieces to be sold there. Approval in a major market has been absent, including the EU, where it is not expected until 2025/2026.
ProVeg supports companies that develop cultivated products through its ProVeg Incubator scheme. the world’s leading incubator for plant-based and cultivated foods. The Incubator offers startups a 12-week accelerator programme with an intensive, tailor-made curriculum, expert mentoring, funding and exclusive networking opportunities to help get products to market.
<<<
---
>>> Meati Foods sinks teeth into $150M to expand its mushroom-root meat operations
TechCrunch
Christine Hall
July 21, 2022
https://techcrunch.com/2022/07/21/meati-foods-150m-plant-based-meat/
Meati Foods, which is developing the Eat Meati brand of proteins made from mushroom root, is poised to begin shipping its plant-based meat product later this year after closing on $150 million in new Series C funding.
The round, which gives the company $278.6 million in total funding, according to Crunchbase data, was led by Revolution Growth, with participation from existing and new investors, including CPP Investments, Grosvenor, Wellington Management and Chipotle Mexican Grill’s new venture fund, Cultivate Next. Meati is among Cultivate’s first cohort of investments.
Founded in 2017, Meati makes whole-cut meats that are 95% mushroom root and have as much as 17 grams of protein, 12 grams of dietary fiber and a healthy dose of zinc and vitamin B12.
The company is among a handful of startups leveraging mycelium, the structural fibers of fungi, to make healthier protein options than traditional animal products. Fellow companies include Perfect Day, MyForest Foods and Fable Food.
We profiled Meati in 2021, when the company announced $46 million in both equity and debt investments. At that time, co-founder and CEO Tyler Huggins, who started Meati with Justin Whiteley, had 30 employees and was starting a pilot plant.
Today, it has 150 people and made its retail debut this month in restaurants throughout Colorado and Arizona after selling mainly online. Meati has had “multiple months of record sellouts” online, and the company has plans to expand its national footprint in the U.S. by 2023, Huggins said.
The new funding enables the company to complete its over 100,000-square-foot Mega Ranch facility in Colorado. Once it ramps up, the facility will have the capability of producing over 45 million pounds of product. In addition, the company is also breaking ground on its first Giga Ranch, a facility it will replicate all over the world, with plans to produce hundreds of millions of pounds annually.
“We will be, at that point, one of the largest single ‘beef’ producers in the United States,” Huggins told TechCrunch. “We will set the gold standard for how we can produce in a clean, nutritious, delicious and sustainable way.”
Huggins plans to get Meati into “10,000 doors by the end of 2023,” with a goal of reaching a $1 billion in revenue run rate by 2025. For now, “it’s more of an issue for us to supply and demand in order to move as fast as we possibly can,” he added.
Indeed, how companies in the plant-based and cultivated meat sectors scale to meet consumer demand has long been a burning question, especially as companies like Meati and UPSIDE Foods take in hundreds of millions of dollars in funding.
For example, this week, Meatable, a Dutch company in the cultivated meat space, unveiled its first pork sausage product but told my colleague Paul Sawers that it is still looking at another three years before it launches commercially.
Therefore, it is promising to finally see companies like Meati and UPSIDE Foods announce how closer they are to broader commercialization of their products.
“The research is done,” Huggins said. “It’s now time to scale. We are continuing to finish out our production facility with the Mega Ranch and lay the groundwork for the Giga brands. We want to have the support mechanisms of staff in place to make sure that we can support this rapid growth.”
<<<
---
Steakholder Foods (STKH) -
>>> MeaTech 3D Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter. The company develops a three-dimensional bioprinter to deposit layers of differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provide associated products, such as cell lines, printheads, bioreactors, and incubators; and offer services, such as technology implementation, training, and engineering support directly and through contractors to food processing and food retail companies. The company is headquartered in Rehovot, Israel.
<<<
---
>>> Instacart is an American company that operates a grocery delivery and pick-up service in the United States and Canada.[5] The company offers its services via a website and mobile app. The service allows customers to order groceries from participating retailers with the shopping being done by a personal shopper.[6]
https://en.wikipedia.org/wiki/Instacart
History
2010s
Instacart was founded in 2012 by entrepreneur Apoorva Mehta, a former Amazon.com employee.[7][8][9] Apoorva was born in India and moved with his family to Canada in 2000.[10][11] He studied engineering at the University of Waterloo and graduated in 2008.[12] He was a participant in Y Combinator's Summer 2012 batch, which eventually led to the creation of Instacart.[13] In 2013, Mehta was included on the Forbes 30 Under 30 list.[14] Apoorva previously worked at BlackBerry, Qualcomm, and then Amazon as a supply chain engineer, where he developed fulfillment systems to move packages from Amazon's warehouses to customers' homes.[15] He left Amazon in 2010 to attempt to start his own business.[16] Before founding Instacart, Apoorva had tried to start at least 20 other services.[14][7] He tried building an ad network for social gaming companies, and developing a social network specifically for lawyers, among other start-ups.[17]
Instacart originally launched in San Francisco.[18][19][20][21] By April 2015, the firm had about 200 employees. It introduced a new policy around June allowing some shoppers to choose to be part-time employees, starting with Chicago and Boston[22][23] and extending its offer to shoppers in Atlanta, Miami, and Washington, D.C. the following month.[24]
In September 2016, the company announced an expansion to its zone on the north side of Chicago.[25] In October 2016, it announced the expansion of coverage areas in Orange County, California,[26] and Minneapolis.[27] In November 2016, the company changed its policy and removed the option to leave a gratuity in exchange for a service fee that would be used to pay workers instead. Backlash against the policy from customers and some shoppers forced the company to reinstate the option only weeks later with modifications that placed the tip under the service fee section on a separate page.[28][29]
In March 2017, Instacart agreed to pay $4.6 million to settle a class action settlement stemming from the alleged misclassification of its personal shoppers as independent contractors. The suit, filed in March 2015, alleged 18 violations, including improper tip pooling and failure to reimburse workers for business expenses.[30][31] The same year, Instacart raised $400 million in funding at a valuation of $3.4 billion.[32][33] In November 2017, the company expanded to Canada by announcing a partnership with Loblaw Companies to begin delivery from select locations in Toronto and Vancouver.[34][35] That same month, some Instacart workers participated in a strike action, alleging wages as low as $1 an hour. Instacart claimed that the strike had no impact on its operations.[36]
In January 2018, the company acquired Toronto-based Unata, a white-label platform for grocers, for $65 million.[37][38][39] In February 2018, Instacart withheld tips given by customers to shoppers, blaming a software bug. In addition, customers were often charged for service fees that were supposed to be waived.[40] In April 2018, Instacart made a few additional changes to its pay service by instituting a mandatory 5% service fee on all orders. It originally offered an optional 10% service fee that went directly to Instacart that could be turned off. It also returned the gratuity option back to the checkout screen and raised the default value from 0% to 5%.[41] By mid-2018, Instacart was available for use in 11 Canadian markets and was planning expansions for five more markets.[42] Later in 2018, the company raised $200 million at a $4.2 billion valuation in a funding round led by Coatue Management, as well as Glade Brook Capital Partners and existing investors.[43] In October 2018, Instacart raised another $600 million at a $7.6 billion valuation in a funding round led by hedge fund D1 Capital Partners.[44] In the fall of 2018, Instacart announced national expansions with retailers, including Walmart Canada stores, Staples Canada, M&M Food Market,[45] Kroger, Aldi, Sam's Club, Publix, and Costco.[46][47] In November 2018, Instacart announced the national expansion of Instacart Pickup, a grocery click-and-collect service, whereby users pick up their pre-packaged orders at the grocery store.[48] In November and December 2018, Instacart again changed its pay system for its personal shoppers; shoppers claimed this pay system resulted in substantially lower pay and boycotted. Instacart customers complained on social media that their orders were being delayed.[49][50][51] At the end of the year, Instacart raised an additional $271 million from investors, including Andreessen Horowitz, Sequoia Capital, Kleiner Perkins, Comcast Ventures, Thrive Capital, Coatue Management, and Valiant Capital, bringing its latest round of fundraising to $871 million at a $7.87 billion valuation.[52]
In February 2019, an online organizing campaign, including shoppers, provided examples of payments as low as $0.80 per delivery. The company announced that it would revise its pay system and give back pay to some workers.[53][54] Under the revised pay system, tips were no longer factored into the minimum base wages, which were newly set at $7–$10 for a full-service shopping order (based on delivery market) and $5 for delivery only.[55][56] In March 2019, Instacart expanded its same-day alcohol delivery service in the U.S.[57] On April 11, 2019, the company expanded its services to offering an on-demand option for its workers, in order to allow workers to work more flexible schedules.[58] Effective May 2019, Whole Foods Market ended its partnership with Instacart.[59][60] By the end of December 2019, Instacart's alcohol delivery service included over 30 new partners in more than 20 states and Washington, D.C., such as Albertsons, Aldi, Sam's Club, BJ's Wholesale Club, Sprouts Farmers Market, The Fresh Market, and Total Wine & More.[61][62]
2020s
In February 2020, Instacart employees in Skokie, Illinois voted to unionize. Instacart said it "will honor" the vote, pending certification of the results. In the lead-up to the election, high-level Instacart managers distributed anti-union literature at a Skokie grocery store where some of the unionizing workers pick up groceries for delivery.[63] At the time, about 12,000 of Instacart's 142,000 workers were employees with the option of unionizing.[64]
From mid-March to mid-April 2020, Instacart hired an additional 300,000 workers to meet the surge in demand for grocery deliveries during the COVID-19 pandemic.[65][66] Data from Apptopia demonstrated a 218% increase in daily downloads as social distancing measures increased.[67] Instacart also introduced new services in response to the pandemic, including a contactless delivery option, safety kits and guidelines for shoppers, and new sick leave policies and pay for those affected by COVID-19.[68][69]
Instacart workers threatened to strike on March 27, 2020 due to a lack of COVID-19 safety measures. A group called the Gig Workers Collective called for a nationwide walk-out to be held on March 30. They had been asking Instacart to provide workers with hazard pay and protective gear, amongst other demands.[70] In early April, Instacart began providing safety kits to workers, with complaints describing a complicated process to order and wait for the kits to arrive.[71] In May, workers reported being denied sick leave despite quarantining under the advice of a doctor. Instacart required that workers either get a positive Covid-19 test or be under a mandatory quarantine by a public health agency or other government agency.[72][73] By June, Instacart changed its sick leave rules in an agreement reached by it and D.C. Attorney General, Karl Racine. Under the agreement, Instacart would provide paid leave to workers who were clinically diagnosed with Covid-19 by a doctor or other medical profession along with those who had a household member contract Covid-19. The agreement also provided access for workers to telemedicine services.[74][75]
In May 2020, Instacart began a partnership with Rite Aid, offering its service across 2,400 locations in 18 states.[76] In August 2020, Instacart entered its first partnership with Walmart in the U.S. to offer same-day delivery services. The partnership is a pilot program beginning in Los Angeles, San Francisco, San Diego, and Tulsa.[77][78] Additional partnerships in June included C&S Wholesale Grocers and Staples.[79][80]
In October 2020, Instacart raised $200 million at a valuation of $17.7 billion in a financing round led by Valiant Capital and D1 Capital Partners.[81]
On January 14, 2021, Instacart announced a vaccine support stipend to provide financial assistance to company shoppers who choose to get the COVID-19 vaccine.[82][83]
On January 21, 2021, the company planned to lay off nearly 2,000 employees, including all of its employees who had voted to unionize. Instacart said that the layoffs were due to stores increasingly using Instacart to have consumers place orders, but have their own employees fulfill the order instead of Instacart's workforce, reducing reliance on Instacart's in-store shoppers.[84][85][86]
As of its most recent funding round, in March 2021, Instacart raised $265 million at a valuation of $39 billion from existing venture capital investors including Andreessen Horowitz, Sequoia and D1 Capital Partners, as well as existing institutional investors like Fidelity and T. Rowe Price.[87] In March 2022, Instacart slashed its valuation by almost 40% to $24 billion.[88]
On July 8, 2021, Instacart announced that it had appointed Board Member Fidji Simo as CEO, while Apoorva Mehta transitioned to Executive Chairman of the Board.[89]
On February 22, 2022, Instacart started to team up with Delta to give clients more ways to earn miles when they link their SkyMiles and Instacart accounts, with special earning bonuses for Instacart+ members.[90][91]
On March 3, 2022, the platform celebrates women's history month by expanding advertising initiative with new $1 million to support Women-Owned Brands.[92]
On March 16, 2022, in partnership with TikTok, Hearst Magazine and Tasty, Instacart launched Shoppable Recipes with new product integrations that allow food creators to make their recipes shoppable on Instacart.[93]
On March 23, Instacart introduced the Instacart Platform, a program with services for retailers. The platform launched with features for advertising, home delivery, and inventory counting.[94][95]
In May 2022, Instacart announced that it had confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission, signalling its intent to go public.[96] Instacart unveiled new partnerships with Canada's top 5 grocers: Metro, Giant Tiger, Galleria Supermarket and more, expanding same-day delivery countrywide.[97]
In June 2022, Instacart+ (formerly Instacart Express) was introduced with new family shopping features, including sharing membership with another family member for free. The membership also allows for shopping-cart collaboration among family members.[98]
In July 2022, Instacart appointed CEO Fidji Simo to succeed Apoorva Mehta as the Board Chair once the company completed its initial public offering.[99] EBT SNAP is now accepted online via the Instacart Platform in 10 additional states- Colorado, Hawaii, Idaho, Louisiana, Montana, New Mexico, Oregon, Utah, Washington, and Wyoming - with launch partners Albertsons Companies and Sprouts Farmers Market.[100]
In September 2022, Instacart announced it would be acquiring Eversight, an AI pricing platform. [101] [102]
Service model
Orders are fulfilled and delivered by a personal shopper, who picks, packs, and delivers the order within the customer's designated time frame—within one hour or up to five days in advance.[103][104] Customers pay with personal debit or credit cards, Google Pay, Apple Pay and EBT cards.[105] The delivery fee is $3.99 for orders of $35 or more and $7.99 under that amount. Regardless of the cost of the order, there is a 5% service fee with a minimum of $2 owed. Instacart offers a membership service called Instacart+, formerly Instacart Express until June 2022, for a monthly fee of about $9.99 or an annual fee of $99. The membership service waives delivery fees on orders over $35, but customers must still pay the service fee for the shopper. Customers are also requested to leave a gratuity.[106] Retailers participating in Instacart's partnership program set the price of individual items on the Instacart marketplace, which are mostly the same prices as in-store.[107] In addition, customers can pick up their pre-made orders from the store through a separate service.[108] For stores that do not participate in Instacart's partnership program, customers can be charged a markup of about 15%-40% per order with individual items ranging from a negative markup to over 50%.[109][110]
<<<
---
Reportedly, the 'all cause' death rate jumped ~ 40% for two quarters last Fall/Winter, which was unprecedented. 'All cause death' is a statistic followed closely by the life insurance industry, and they were reportedly freaked out about it. Funeral directors and embalmers were also reportedly alarmed by "weird, freakishly large blood clots clogging veins in vaccinated bodies" -
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167944156
Even without the scientific and media blackout of this type of info, it would be very difficult to figure out how much of the observed effects are from the vaccines, and how much from Covid itself. People are being exposed and re-exposed to the live virus daily, and as a virus, Covid can presumably live inside the body for months, years, maybe forever. In contrast, the spike protein produced by the vaccines is present in the body for only a short time. The vaccines do also have the nano-lipid component, which might have its own potential for toxicity.
So lots of unknowns, and plenty of reasons to be wary of both the virus and the vaccines. The virus most likely came out of a lab, and the mRNA vaccines are new and experimental, and without the usual long term safety studies. Add to this the fact that many/most people have come to distrust both big pharma and big government, for good reason. Both lie routinely, so In legal speak - 'falsus uno, falsus omnibus'.
---
Name | Symbol | % Assets |
---|---|---|
Chr. Hansen Holding A/S | CHR | 22.41% |
The Hain Celestial Group Inc | HAIN | 10.42% |
Sprouts Farmers Market Inc | SFM | 10.16% |
Ariake Japan Co Ltd | 2815 | 6.03% |
Cal-Maine Foods Inc | CALM | 4.48% |
Treatt PLC | TET.L | 4.01% |
John B Sanfilippo & Son Inc | JBSS | 3.95% |
Freedom Foods Group Ltd | FNP.AX | 3.78% |
L'Occitane International SA | 00973.HK | 3.59% |
United Natural Foods Inc | UNFI | 3.50% |
Name | Symbol | % Assets |
---|---|---|
Givaudan SA | GIVN | 6.21% |
Corteva Inc | CTVA | 5.78% |
Nutrien Ltd | NTR.TO | 4.24% |
International Flavors & Fragrances Inc | IFF | 3.91% |
Mowi ASA | MOWI | 3.75% |
Symrise AG | SY1.DE | 3.57% |
Kerry Group PLC Class A | KYGA.L | 3.39% |
FMC Corp | FMC | 3.31% |
Zoetis Inc Class A | ZTS | 3.18% |
Ecolab Inc | ECL | 3.14% |
Name | Symbol | % Assets |
---|---|---|
Deere & Co | DE | 20.51% |
Corteva Inc | CTVA | 6.75% |
Archer-Daniels Midland Co | ADM | 6.52% |
Nutrien Ltd | NTR.TO | 5.83% |
Kubota Corp | 6326 | 4.50% |
FMC Corp | FMC | 2.85% |
CNH Industrial NV | CNHI.L | 2.83% |
The Mosaic Co | MOS | 2.35% |
The Toro Co | TTC | 2.28% |
Bunge Ltd | BG | 2.19% |
Name | Symbol | % Assets |
---|---|---|
Zoetis Inc Class A | ZTS | 8.78% |
Deere & Co | DE | 7.87% |
IDEXX Laboratories Inc | IDXX | 6.99% |
Bayer AG | BAYN.DE | 6.71% |
Nutrien Ltd | NTR.TO | 5.55% |
Corteva Inc | CTVA | 5.47% |
Archer-Daniels Midland Co | ADM | 5.03% |
Kubota Corp | 6326 | 4.30% |
Tractor Supply Co | TSCO | 3.73% |
Tyson Foods Inc Class A | TSN | 3.50% |
Name | Symbol | % Assets |
---|---|---|
Deere & Co | DE | 19.38% |
Corteva Inc | CTVA | 9.27% |
Nutrien Ltd | NTR.TO | 7.23% |
Archer-Daniels Midland Co | ADM | 5.87% |
Darling Ingredients Inc | DAR | 4.68% |
Fidelity Revere Str Tr | N/A | 4.29% |
FMC Corp | FMC | 4.20% |
Kubota Corp | 6326 | 3.93% |
CF Industries Holdings Inc | CF | 3.71% |
Lamb Weston Holdings Inc | LW | 3.31% |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |